Kinvard Bio

Raleigh, United States

Kinvard Bio is a biotech startup launched by Kineticos Life Sciences to combat antimicrobial resistance.

$2.7M raised

Jul 2025

Grant

Top Investors

CARB-XKineticos Life Sciences

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Kinvard Bio raised?

Kinvard Bio has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in July 2025.

Who are Kinvard Bio's investors?

Kinvard Bio's investors include CARB-X, Kineticos Life Sciences.

Where is Kinvard Bio headquartered?

Kinvard Bio is headquartered in Raleigh, United States.

What does Kinvard Bio do?

Kinvard Bio is a biotech startup launched by Kineticos Life Sciences to combat antimicrobial resistance.

What stage is Kinvard Bio at?

Kinvard Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 29, 2025.

MLA

"Kinvard Bio — Funding & Investors." VCBacked, July 29, 2025, https://www.vcbacked.co/company/kinvard-bio. Accessed July 1, 2026.

APA

VCBacked. (2025). Kinvard Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/kinvard-bio

Wikipedia (cite web)

{{cite web |title=Kinvard Bio — Funding & Investors |url=https://www.vcbacked.co/company/kinvard-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 29, 2025.